we are in need to describe investigations for our patients but over prescription of these investigations especially if unnecessary could be considered abuse
9. Impact of Inappropriate Lab Utilization
Financial Burden
Medical
Unnecessary blood draws
Phlebotomy acquired anemia
.
Increased Costs
Patient?
Center ?
Likelihood of false-positive
results
17. Does PGS help increase pregnancy rate in IVF?
1
7
Moniek Twisk et al., Hum Reprod; 20013
18. •
Cost-effectiveness analysis of PGS and IVF
versus expectant management in patients with
unexplained recurrent pregnancy loss
Unexplained RPL, IVF/PGS with 24-CCS (232)and
expectant management (302)
Main Outcomes Measure(s):Cost /LB.
Result(s): LBR and miscarriage were 53% and 7%.
IVF/PGS and 67% and 24% in expectant. PGS 100-fold
more expensive, $45,300/LB compared $418/LB with
expectant.
Conclusion(s):IVF/PGS not cost-effective.
LBR with IVF/PGS needs to be 91% to be cost
effective compared with expectant.
Murugappan, et al., Fertility Sterility, 2015
20. Practical Steps to combat the problem
Diagnostic
Algorithms
Evidence Based Cost
effectiveness
System
Approach
21. Abnormal sperm count
Normal sperm analysis, eugonadal
No tests are required Measure testosterone,
gonadotrophins, and Prolactin
Testosterone
Gonadotrophins
Testosterone
Gonadotrophins
Testosterone
Prolactin
Diagnostic approach for man
History & examination
Primary testicular failure
Hypogonadotrophic
hypogonadism: due to
hypothalamic-pituitary
disease
Hyperprolactinaemia: rare
22. History & Examination
Amenorrhoea, Oligomenorrhoea
Normal menses
?Ovulating
Measure [Progesterone] in day 21 (mid luteal)
Perform pregnancy
test
Further tests
indicated
+ ve
Measure [LH], [FSH], & [Prolactin]
High FSH. (+ LH)
>30nmol/L <10nmol/L
Ovarian failure
Ovulating Not ovulating
No
further
tests
required
-ve
High LH
Low FSH
PCOS
High
Prolactin
Further investigate
hyperprolactinaemia
All Normal
Diagnostic approach to anovulatory woman
24. Commercially available without evidence
the ERA test (Endometrial
Receptivity Array) :
a customized array based on the
expression of 238 genes coupled
to a computational predictor
capable of diagnosing a
functionally receptive
endometrium.(Diaz-Gimeno P et
al.,2011)
25. - Recurrent implantation failure
- Single embryo transfer (sET). (Barzilay Eran et al.,2018)
- endometrial biopsy must be performed at P+5 (hormone replacement
therapy cycle) or at LH+7 (natural cycle)
Invasive
26. But
• No RCT have been conducted
• Commercially propagated without clear
evidence
• Very expensive
27. Question
• Why to jump from research to practice
without evidence?
• Who pay for it ?
• Does it really improve pregnancy rate?
Example: If test probability is only 1% and the test is false positive result can mislead the diagnosis.
Or Thyroid profiling in a ICU patient give false results.